Literature DB >> 12584357

Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation.

David A Davis1, Cara A Brown, Fonda M Newcomb, Emily S Boja, Henry M Fales, Joshua Kaufman, Stephen J Stahl, Paul Wingfield, Robert Yarchoan.   

Abstract

Human immunodeficiency virus protease activity can be regulated by reversible oxidation of a sulfur-containing amino acid at the dimer interface. We show here that oxidation of this amino acid in human immunodeficiency virus type 1 protease prevents dimer formation. Moreover, we show that human T-cell leukemia virus type 1 protease can be similarly regulated through reversible glutathionylation of its two conserved cysteine residues. Based on the known three-dimensional structures and multiple sequence alignments of retroviral proteases, it is predicted that the majority of retroviral proteases have sulfur-containing amino acids at the dimer interface. The regulation of protease activity by the modification of a sulfur-containing amino acid at the dimer interface may be a conserved mechanism among the majority of retroviruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584357      PMCID: PMC149757          DOI: 10.1128/jvi.77.5.3319-3325.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

2.  HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation.

Authors:  I Ventoso; R Blanco; C Perales; L Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

3.  HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.

Authors:  L D Adams; A G Tomasselli; P Robbins; B Moss; R L Heinrikson
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

4.  Construction of mutant and chimeric genes using the polymerase chain reaction.

Authors:  F Vallette; E Mege; A Reiss; M Adesnik
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

5.  Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection.

Authors:  Y Rivière; V Blank; P Kourilsky; A Israël
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

6.  HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase.

Authors:  D A Davis; F M Newcomb; J Moskovitz; P T Wingfield; S J Stahl; J Kaufman; H M Fales; R L Levine; R Yarchoan
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

7.  Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.

Authors:  J Tözsér; G Zahuczky; P Bagossi; J M Louis; T D Copeland; S Oroszlan; R W Harrison; I T Weber
Journal:  Eur J Biochem       Date:  2000-10

8.  Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus.

Authors:  A G Tomasselli; J O Hui; L Adams; J Chosay; D Lowery; B Greenberg; A Yem; M R Deibel; H Zürcher-Neely; R L Heinrikson
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases.

Authors:  S K Grant; I C Deckman; J S Culp; M D Minnich; I S Brooks; P Hensley; C Debouck; T D Meek
Journal:  Biochemistry       Date:  1992-10-06       Impact factor: 3.162

10.  Non-viral cellular substrates for human immunodeficiency virus type 1 protease.

Authors:  R L Shoeman; C Kesselmier; E Mothes; B Höner; P Traub
Journal:  FEBS Lett       Date:  1991-01-28       Impact factor: 4.124

View more
  15 in total

Review 1.  The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer.

Authors:  Kenneth D Tew; Yefim Manevich; Christina Grek; Ying Xiong; Joachim Uys; Danyelle M Townsend
Journal:  Free Radic Biol Med       Date:  2011-04-22       Impact factor: 7.376

2.  The cellular redox environment alters antigen presentation.

Authors:  Jonathan A Trujillo; Nathan P Croft; Nadine L Dudek; Rudragouda Channappanavar; Alex Theodossis; Andrew I Webb; Michelle A Dunstone; Patricia T Illing; Noah S Butler; Craig Fett; David C Tscharke; Jamie Rossjohn; Stanley Perlman; Anthony W Purcell
Journal:  J Biol Chem       Date:  2014-08-18       Impact factor: 5.157

3.  Understanding HIV-1 protease autoprocessing for novel therapeutic development.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

Review 4.  Thioredoxins, glutaredoxins, and glutathionylation: new crosstalks to explore.

Authors:  Laure Michelet; Mirko Zaffagnini; Vincent Massot; Eliane Keryer; Hélène Vanacker; Myroslawa Miginiac-Maslow; Emmanuelle Issakidis-Bourguet; Stéphane D Lemaire
Journal:  Photosynth Res       Date:  2006-11-07       Impact factor: 3.573

5.  Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach.

Authors:  David A Davis; Irene R Tebbs; Sarah I Daniels; Stephen J Stahl; Joshua D Kaufman; Paul Wingfield; Michael J Bowman; Jean Chmielewski; Robert Yarchoan
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

Review 6.  S-glutathionylation: from redox regulation of protein functions to human diseases.

Authors:  Daniela Giustarini; R Rossi; A Milzani; R Colombo; Isabella Dalle-Donne
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

Review 7.  Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.

Authors:  Melissa D Shelton; John J Mieyal
Journal:  Mol Cells       Date:  2008-05-16       Impact factor: 5.034

8.  The initial step in human immunodeficiency virus type 1 GagProPol processing can be regulated by reversible oxidation.

Authors:  Sarah I Daniels; David A Davis; Erin E Soule; Stephen J Stahl; Irene R Tebbs; Paul Wingfield; Robert Yarchoan
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

9.  Basal Glutathionylation of Na,K-ATPase α-Subunit Depends on Redox Status of Cells during the Enzyme Biosynthesis.

Authors:  Vladimir A Mitkevich; Irina Yu Petrushanko; Yuri M Poluektov; Ksenia M Burnysheva; Valentina A Lakunina; Anastasia A Anashkina; Alexander A Makarov
Journal:  Oxid Med Cell Longev       Date:  2016-04-27       Impact factor: 6.543

10.  Virus-producing cells determine the host protein profiles of HIV-1 virion cores.

Authors:  Steven Santos; Yuri Obukhov; Sergei Nekhai; Michael Bukrinsky; Sergey Iordanskiy
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.